C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 451/04 (2006.01) A61K 31/46 (2006.01) A61P 31/18 (2006.01)
Patent
CA 2509711
The present invention relates to compounds of formula (I) or pharmaceutically acceptable derivatives thereof, useful in the treatment or prophylaxis of CCR5- related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
La présente invention porte sur des composés de formule (I) ou sur leurs dérivés acceptables d'un point de vue pharmaceutique, ces composés étant utiles dans le traitement ou la prophylaxie des maladies ou troubles liés à CCR5, par exemple, dans l'inhibition de la réplication du VIH, la prévention ou le traitement d'une infection provoquée par le VIH et dans le traitement du syndrome d'immunodéficience acquise (SIDA) en résultant.
Aquino Christopher Joseph
Bifulco Neil
Boros Eric Eugene
Chauder Brian Andrew
Chong Pek Yoke
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Smithkline Beecham Corporation
LandOfFree
Piperidine derivatives as ccr5 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives as ccr5 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as ccr5 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1882964